TUESDAY, Oct. 26, 2021 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) concludes that proof for weighing the stability of advantages and harms of screening adults aged 40 years or older for major open-angle glaucoma is at the moment insufficient. These findings type the premise of a draft suggestion assertion printed on-line Oct. 26 by the USPSTF.Roger Chou, M.D., from the Oregon Health & Science University in Portland, and colleagues performed a scientific overview of the proof on screening and therapy of glaucoma for populations and settings related to U.S. major care. The overview included 83 research with 76,807 contributors. The researchers discovered that imaginative and prescient screening by an optometrist was related to no distinction in visible acuity or imaginative and prescient-associated high quality of life in contrast with no screening in a single randomized managed trial (616 contributors), however the threat for falls was elevated. The results of referral to an eye fixed well being supplier versus no referral on imaginative and prescient or different well being outcomes weren’t evaluated in any examine. Compared with placebo or no therapy, medical remedy for ocular hypertension and untreated glaucoma was related to a better discount in intraocular stress, diminished probability of glaucoma development, and an elevated threat for ocular hostile occasions (16 trials).Based on these findings, the USPSTF concludes that for adults aged 40 years or older with out indicators or signs of open-angle glaucoma, the proof is at the moment inadequate to evaluate the stability of advantages and harms for screening for major open-angle glaucoma (I assertion).The draft suggestion assertion and proof overview have been posted for public remark. Comments could be submitted from Oct. 26 to Nov. 22, 2021.Draft Evidence OverviewDraft Recommendation StatementTouch upon Recommendation Statement
USPSTF: Evidence Lacking for Open-Angle Glaucoma Screening – Consumer Health News
